// App-Quantinova.ai

P-332 : Real-world data study of BRAF mutant metastatic colorectal cancer patients across the Greater Manchester region prior to BEACON trial results

Researchers

Presenter

  • R. Cairns

Principal Investigators

  • M. Brown

  • M. Al-Ani

  • G. Burghel

  • S. Mullamitha

  • F. Marti Marti

  • J. Hasan

  • K. Kamposioras

  • A. Alchawaf

  • V. Lavin

  • N. Alam

  • C. Arthur

  • V. Misra

  • M. Nasralla

  • M. Saunders

  • A. Wallace

  • M. Braun

  • J. Barriuso

Medical Centers

  • University of Manchester and The Christie NHS FT, Manchester, United Kingdom

  • Manchester Centre for Genomic Medicine, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

Biomarkers

  • B-Raf proto-oncogene, serine/threonine kinase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved